1. Home
  2. MBX vs KELYA Comparison

MBX vs KELYA Comparison

Compare MBX & KELYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBX
  • KELYA
  • Stock Information
  • Founded
  • MBX 2018
  • KELYA 1946
  • Country
  • MBX United States
  • KELYA United States
  • Employees
  • MBX N/A
  • KELYA N/A
  • Industry
  • MBX
  • KELYA Professional Services
  • Sector
  • MBX
  • KELYA Consumer Discretionary
  • Exchange
  • MBX NYSE
  • KELYA Nasdaq
  • Market Cap
  • MBX 381.4M
  • KELYA 403.0M
  • IPO Year
  • MBX 2024
  • KELYA N/A
  • Fundamental
  • Price
  • MBX $13.29
  • KELYA $12.46
  • Analyst Decision
  • MBX Strong Buy
  • KELYA Buy
  • Analyst Count
  • MBX 5
  • KELYA 1
  • Target Price
  • MBX $37.40
  • KELYA $25.00
  • AVG Volume (30 Days)
  • MBX 365.8K
  • KELYA 274.9K
  • Earning Date
  • MBX 08-16-2025
  • KELYA 08-07-2025
  • Dividend Yield
  • MBX N/A
  • KELYA 2.36%
  • EPS Growth
  • MBX N/A
  • KELYA N/A
  • EPS
  • MBX N/A
  • KELYA N/A
  • Revenue
  • MBX N/A
  • KELYA $4,451,600,000.00
  • Revenue This Year
  • MBX N/A
  • KELYA $8.06
  • Revenue Next Year
  • MBX N/A
  • KELYA $4.08
  • P/E Ratio
  • MBX N/A
  • KELYA N/A
  • Revenue Growth
  • MBX N/A
  • KELYA N/A
  • 52 Week Low
  • MBX $4.81
  • KELYA $10.80
  • 52 Week High
  • MBX $27.50
  • KELYA $23.81
  • Technical
  • Relative Strength Index (RSI)
  • MBX N/A
  • KELYA 58.90
  • Support Level
  • MBX N/A
  • KELYA $12.36
  • Resistance Level
  • MBX N/A
  • KELYA $12.87
  • Average True Range (ATR)
  • MBX 0.00
  • KELYA 0.33
  • MACD
  • MBX 0.00
  • KELYA 0.11
  • Stochastic Oscillator
  • MBX 0.00
  • KELYA 77.72

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

About KELYA Kelly Services Inc.

Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.

Share on Social Networks: